Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

5-Hydroxytryptamine-receptor subtypes.

O E Brodde1

  • 1Biochemisches Forschungslabor, Medizinische Klinik und Poliklinik, Abteilung für Nieren- und Hochdruckkrankheiten, Universitätsklinikum, Essen, FRG.

Clinical Physiology and Biochemistry
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits.

British journal of pharmacology·2010
Same author

Regulation of equine lymphocyte beta-adrenoceptors under the influence of clenbuterol and dexamethasone.

Equine veterinary journal·2002
Same author

Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart.

Basic research in cardiology·2002
Same author

Noradrenaline-induced increase in protein synthesis in adult rat cardiomyocytes: involvement of only alpha1A-adrenoceptors.

Naunyn-Schmiedeberg's archives of pharmacology·2001
Same author

Muscarinic receptors in the mammalian heart.

Pharmacological research·2001
Same author

Impaired beta-adrenergic control of immune function in patients with chronic heart failure: reversal by beta1-blocker treatment.

Basic research in cardiology·2001
Same journal

Indomethacin and meclofenamate do not alter ACTH and cortisol responses to corticotropin-releasing hormone (CRH) in normal subjects.

Clinical physiology and biochemistry·1993
Same journal

Retroviral interference with neuronotrophic signaling in human motor neuron disease?

Clinical physiology and biochemistry·1993
Same journal

Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis.

Clinical physiology and biochemistry·1993
Same journal

Partial prevention of glutathione depletion in rats following acute intoxication with diethylmaleate.

Clinical physiology and biochemistry·1993
Same journal

Influence of acute and chronic smoking on leukocyte aggregation.

Clinical physiology and biochemistry·1993
Same journal

Urinary calcium and renal function in the Japanese female population.

Clinical physiology and biochemistry·1993
See all related articles

The classification of serotonin (5-Hydroxytryptamine or 5-HT) receptors has evolved from simple M and D subtypes to recognizing at least four main families (5-HT1, 5-HT2, 5-HT3, 5-HT4). These receptor subtypes differ in their signal transduction mechanisms and further subdivisions, particularly within the 5-HT1 family.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Molecular Biology

Background:

  • Serotonin (5-Hydroxytryptamine or 5-HT) receptors were initially classified into M and D subtypes based on their distinct mechanisms of action on guinea-pig ileum contraction.
  • This early classification proved to be an oversimplification with the advent of advanced research techniques.

Purpose of the Study:

  • To review the current understanding of 5-Hydroxytryptamine (5-HT) receptor classification and their signal transduction pathways.
  • To highlight the heterogeneity within 5-HT receptor families, particularly the 5-HT1 subtypes.

Main Methods:

  • Review of radioligand-binding studies.
  • Analysis of data from selective 5-HT agonists and antagonists.
  • Examination of differences in signal-transduction mechanisms.

Related Experiment Videos

Main Results:

  • The existence of at least four main families of 5-HT receptors (5-HT1, 5-HT2, 5-HT3, and possibly 5-HT4) is now accepted.
  • The 5-HT1 family is further subdivided into 5-HT1A, 5-HT1B, 5-HT1C, and 5-HT1D subtypes.
  • Different 5-HT receptor subtypes exhibit distinct signal transduction pathways: 5-HT1 receptors (except 5-HT1C) are linked to adenylate cyclase (inhibitory or excitatory), 5-HT2 receptors (and 5-HT1C) to PI turnover, and 5-HT3 receptors to ion channels.

Conclusions:

  • The classification of 5-HT receptors has significantly advanced beyond initial models, revealing complex heterogeneity.
  • Understanding the distinct signal transduction mechanisms of various 5-HT receptor subtypes is crucial for their pharmacological characterization and therapeutic targeting.